Kroger extends partnership with Express Scripts to improve drug access and affordability
This partnership strengthens Kroger's commitment to accessible healthcare and affordable prescriptions.
Pharmacy
Upcoming NCPA items for pharmacy teams
Additionally, registration is open for NCPA’s 2025 Congressional Pharmacy Fly-In, taking place April 30 – May 1 in Alexandria, Va., and Washington, D.C.
CVS teams with Duquesne University to help address pharmacist shortage
Collaboration removes financial barriers to higher education and supports talent pipeline for future pharmacists.
NACDS highlights “Four Wins for a Healthier America” as Trump declares February American Heart Month
NACDS is urging policymakers and stakeholders to prioritize policies that support these "Four Wins" to create a healthier America.
Abbott releases "Above the Bias" film to fight diabetes stigma
The film highlights the emotional and psychological challenges faced by individuals living with diabetes.
Senate panel advances RFK Jr.'s nomination to be health secretary
The committee voted for RFK Jr. 14-13, sending his nomination to the Senate floor for a vote, probably next week.
Association for Accessible Medicines unveils 2025 advocacy priorities
“This is not just about dollars and cents—it is about lives,” says AAM President Dan Leonard.
Walgreens marks one-year anniversary of Deans Advisory Council
The Council’s first year delivers tangible solutions to strengthen pharmacy talent pipeline and transform the future of pharmacy.
Ardena completes acquisition of advanced drug product manufacturing facility from Catalent
The Somerset, N.J. facility encompasses over 50,000 sq ft of cGMP manufacturing space and is home to over 200 skilled scientists and technicians.
FDA approves Journavx for moderate to severe acute pain
Journavx is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years.
Public Citizen: Trump must stop war on science and public health
“Professional associations, medical journal editors, the National Academy of Medicine and other leaders must speak out in defense of science and public health. Silence in this critical moment is the wrong choice.”
Biosimilar void is a crisis in patient access according to IQVIA report
“Biosimilars are making more therapies more available for America’s patients, but too many government policies are slowing biosimilar development and adoption,” said Craig Burton, executive director of the Biosimilars Council.
SDS Rx announces David Emison as president
New leadership position focuses on driving innovation, growth and service excellence.
GLP-1 medications transform treatments for diabetes, weight-loss
Texas A&M pharmacist says the injectable drugs change lives with unprecedented health benefits
Quest Diagnostics named to Fortune's World's Most Admired Companies List for 11th year
The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, social responsibility, and talent management.
Walgreens Boots Alliance halts quarterly dividend to enhance financial stability
The decision aims to strengthen WBA’s balance sheet by reducing debt and improving free cash flow.